Polymorph determination for the GP IIb/IIIa antagonist, roxifiban, using a combination of electron diffraction and synchrotron X-ray powder diffraction techniques.
- DOI
- 10.1021/js9803306
- Published
- 1999 Mar
- Container
- Journal of pharmaceutical sciences
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/js9803306,
title = {Polymorph determination for the GP IIb/IIIa antagonist, roxifiban, using a combination of electron diffraction and synchrotron X-ray powder diffraction techniques.},
author = {Li ZG and Harlow RL and Foris CM and Li H and Ma P and Vickery RD and Maurin MB and Toby BH},
year = {1999},
journal = {Journal of pharmaceutical sciences},
doi = {10.1021/js9803306},
url = {https://doi.org/10.1021/js9803306}
}RIS
TY - JOUR TI - Polymorph determination for the GP IIb/IIIa antagonist, roxifiban, using a combination of electron diffraction and synchrotron X-ray powder diffraction techniques. AU - Li ZG AU - Harlow RL AU - Foris CM AU - Li H AU - Ma P AU - Vickery RD AU - Maurin MB AU - Toby BH PY - 1999 JO - Journal of pharmaceutical sciences DO - 10.1021/js9803306 UR - https://doi.org/10.1021/js9803306 ER -
APA
ZG, L., RL, H., CM, F., H, L., P, M., RD, V., MB, M., & BH, T. (1999). Polymorph determination for the GP IIb/IIIa antagonist, roxifiban, using a combination of electron diffraction and synchrotron X-ray powder diffraction techniques.. Journal of pharmaceutical sciences. https://doi.org/10.1021/js9803306
Source records
- pubmed · retrieved 2026-09-25T06:05:50.688Z